Search

Search Constraints

You searched for: Author/Creator Piccillo, Giovita

Search Results

1. SPOSAB ABP 501 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501. (21st January 2021)

2. SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501. Issue 11 (3rd July 2021)

3. The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches. Issue 2 (19th January 2021)

4. The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches. Issue 2 (21st February 2020)

5. Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease. Issue 5 (May 2022)